Thus, the transcriptional activation of the Nr4a1/Ear2‐axis may be a key mechanism through which deletion of myeloid‐TLR4 promoted anti‐inflammatory macrophage differentiation and immunosuppression in anti‐GBM cGN. The gene discussed is NR2F6; the disease is glioblastoma.